Abstract:BACKGROUND:Diabetes mellitus is characterized by loss or dysfunction of insulin-producing β-cells in the pancreas, resulting in failure of blood glucose regulation and devastating secondary complications. Thus, β-cells are currently the prime target for cell-replacement and regenerative therapy. Triggering endogenous repair is a promising strategy to restore β-cell mass and normoglycemia in diabetic patients. Potential strategies include targeting specific β-cell subpopulations to increase proliferation or maturation. Alternatively, transdifferentiation of pancreatic islet cells (e.g. α- or δ-cells), extra-islet cells (acinar and ductal cells), hepatocytes, or intestinal cells into insulin-producing cells might improve glycemic control. To this end, it is crucial to systematically characterize and unravel the transcriptional program of all pancreatic cell types at the molecular level in homeostasis and disease. Furthermore, it is necessary to better determine the underlying mechanisms of β-cell maturation, maintenance, and dysfunction in diabetes, to identify and molecularly profile endocrine subpopulations with regenerative potential, and to translate the findings from mice to man. Recent approaches in single-cell biology started to illuminate heterogeneity and plasticity in the pancreas that might be targeted for β-cell regeneration in diabetic patients.SCOPE OF REVIEW:This review discusses recent literature on single-cell analysis including single-cell RNA sequencing, single-cell mass cytometry, and flow cytometry of pancreatic cell types in the context of mechanisms of endogenous β-cell regeneration. We discuss new findings on the regulation of postnatal β-cell proliferation and maturation. We highlight how single-cell analysis recapitulates described principles of functional β-cell heterogeneity in animal models and adds new knowledge on the extent of β-cell heterogeneity in humans as well as its role in homeostasis and disease. Furthermore, we summarize the findings on cell subpopulations with regenerative potential that might enable the formation of new β-cells in diseased state. Finally, we review new data on the transcriptional program and function of rare pancreatic cell types and their implication in diabetes.MAJOR CONCLUSION:Novel, single-cell technologies offer high molecular resolution of cellular heterogeneity within the pancreas and provide information on processes and factors that govern β-cell homeostasis, proliferation, and maturation. Eventually, these technologies might lead to the characterization of cells with regenerative potential and unravel disease-associated changes in gene expression to identify cellular and molecular targets for therapy.

“Omics” and “epi-omics” underlying the β-cell adaptation to insulin resistance

Systematic Single-Cell Analysis Provides New Insights into Heterogeneity and Plasticity of the Pancreas.

Pancreatic β-Cell Identity Change through the Lens of Single-Cell Omics Research

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Β-Cell Dynamics in Type 2 Diabetes and in Dietary and Exercise Interventions

Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus

Metabolic Adaptions/Reprogramming in Islet Beta-Cells in Response to Physiological Stimulators—What Are the Consequences

1769-P: Single-Nucleus Multiomics Reveals Unique Molecular Signatures of ß-Cell Heterogeneity and Compensation in Human Obesity

Unique features of β‐cell metabolism are lost in type 2 diabetes

Targeting β-Cell Plasticity: A Promising Approach for Diabetes Treatment

Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in db/db Mice

Identification of Key Gene Pathways and Coexpression Networks of Islets in Human Type 2 Diabetes.

Metabolic Stress and Compromised Identity of Pancreatic Beta Cells

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

Mitochondrial bioenergetics, metabolism, and beyond in pancreatic β-cells and diabetes

Exploring the design of clinical research studies on the efficacy mechanisms in type 2 diabetes mellitus

Update on the transdifferentiation of pancreatic cells into functional beta cells for treating diabetes

Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes

Inside the β Cell: Molecular Stress Response Pathways in Diabetes Pathogenesis

Inter-organ crosstalk during development and progression of type 2 diabetes mellitus

Glucose metabolism partially regulates β‐cell function through epigenomic changes